ACRV vs. BVS
ACRV (Acrivon Therapeutics Inc. Common Stock) and BVS (Bioventus Inc.) are both stocks. Both are in the Healthcare sector — ACRV in Biotechnology, BVS in Medical Devices. Over the past 3 years, ACRV returned -50.76%/yr vs 45.92%/yr for BVS. At a 0.15 correlation, their price movements are largely independent.
Performance
ACRV vs. BVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACRV achieves a -32.37% return, which is significantly lower than BVS's 24.87% return.
ACRV
- 1D
- 3.16%
- 1M
- -6.86%
- YTD
- -32.37%
- 6M
- -29.74%
- 1Y
- 38.14%
- 3Y*
- -50.76%
- 5Y*
- —
- 10Y*
- —
BVS
- 1D
- 5.69%
- 1M
- 0.11%
- YTD
- 24.87%
- 6M
- 23.37%
- 1Y
- 42.48%
- 3Y*
- 45.92%
- 5Y*
- -12.44%
- 10Y*
- —
ACRV vs. BVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ACRV Acrivon Therapeutics Inc. Common Stock | -32.37% | -59.97% | 22.36% | -57.29% | -13.71% |
BVS Bioventus Inc. | 24.87% | -29.14% | 99.24% | 101.92% | -17.14% |
Correlation
The correlation between ACRV and BVS is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Nov 15, 2022 | 0.15 |
Fundamentals
ACRV:
$63.12M
BVS:
$650.38M
ACRV:
-$2.00
BVS:
$0.41
ACRV:
0.66
BVS:
3.44
ACRV:
$0.00
BVS:
$576.30M
ACRV:
$311.00K
BVS:
$390.14M
ACRV:
-$84.65M
BVS:
$98.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACRV vs. BVS — Risk / Return Rank
ACRV
BVS
ACRV vs. BVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Acrivon Therapeutics Inc. Common Stock (ACRV) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACRV | BVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.42 | ||
| Sortino ratioReturn per unit of downside risk | -0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.19 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.67 | 1.55 | -0.88 |
| Martin ratioReturn relative to average drawdown | 1.26 | 4.92 | -3.66 |
Loading charts...
Drawdowns
ACRV vs. BVS - Drawdown Comparison
The maximum ACRV drawdown since its inception was -95.47%, roughly equal to the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for ACRV and BVS.
Loading charts...
Drawdown Indicators
| ACRV | BVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.47% | -95.18% | -0.29% |
Max Drawdown (1Y)Largest decline over 1 year | -57.14% | -27.51% | -29.63% |
Max Drawdown (3Y)Largest decline over 3 years | -92.31% | -55.22% | -37.09% |
Max Drawdown (5Y)Largest decline over 5 years | — | -95.07% | — |
Current DrawdownCurrent decline from peak | -92.97% | -51.64% | -41.33% |
Average DrawdownAverage peak-to-trough decline | -70.67% | -56.32% | -14.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.37% | 8.65% | +21.72% |
Volatility
ACRV vs. BVS - Volatility Comparison
Acrivon Therapeutics Inc. Common Stock (ACRV) and Bioventus Inc. (BVS) have volatilities of 14.33% and 14.78%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACRV | BVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.33% | 14.78% | -0.45% |
Volatility (6M)Calculated over the trailing 6-month period | 72.91% | 33.00% | +39.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.04% | 50.96% | +41.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 104.09% | 81.09% | +23.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 104.09% | 80.64% | +23.45% |
Dividends
ACRV vs. BVS - Dividend Comparison
Neither ACRV nor BVS has paid dividends to shareholders.
Financials
ACRV vs. BVS - Financials Comparison
This section allows you to compare key financial metrics between Acrivon Therapeutics Inc. Common Stock and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ACRV and BVS have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BVS has higher volatility (14.78%) compared to ACRV (14.33%). In terms of maximum drawdown, ACRV dropped -95.47% vs BVS's -95.18%.
BVS currently has the higher Sharpe Ratio (0.84 vs 0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACRV and BVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer